ARMP Operating Cash Flow (Statement)

Armata Pharmaceuticals, Inc. Common Stock · Operating Cash Flow (Statement)

ARMP logo

ARMP Operating Cash Flow (Statement)

Latest reported-$25.42M
ARMP TTM Cash from Operations (-$8.50M → -$25.42M)
High-resolution chart · PNG

ARMP operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Armata Pharmaceuticals, Inc. Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-25,420,000
-23,965,000
-25,763,000
-27,016,000
-31,581,000
-34,547,000
-37,551,000
-37,730,000
-38,554,000
-40,437,000
-47,423,000
-49,802,000
-50,448,000
-46,536,000
-32,481,000
-30,594,000
-25,225,000
-21,615,000
-23,575,000
-21,279,000
-20,195,000
-19,513,000
-18,270,000
-14,697,000
-15,384,000
-17,194,000
-15,582,000
-15,281,000
-11,959,000
-8,466,000
-9,382,000
-9,323,000
-8,671,000
-9,429,000
-9,192,000
-8,304,000
-10,842,000
-10,803,000
-10,589,000
-11,425,000
-10,791,000
-10,561,000
-9,781,000
-10,669,000
-10,814,000
-11,190,000
-12,572,000
-11,935,000
-11,787,000
-10,016,000
-7,448,000
-3,633,000
-2,581,000
-2,608,000
-5,357,000
-9,831,000
-8,054,000
-10,305,000
-10,139,000
-11,181,000
-14,389,000
-13,882,000
-12,294,000
-10,907,000
-11,798,000
-11,636,000
-12,478,000
-15,189,000
-15,973,000
-16,391,000
-16,647,000
-16,501,000
-15,407,000
-15,523,000
-16,995,000
-14,793,000
-14,583,000
-11,230,000
-12,122,000
-12,628,000
-14,150,000
-20,096,000
-21,940,718
-23,950,029
-24,636,950
-23,543,000
-17,010,325
-6,043,621
-2,616,794
-605,544
-1,617,501
-9,823,894
-10,597,800
-10,600,000
-5,300,000
-5,400,000
-5,900,000
-5,800,000
-12,900,000
-12,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.